Last reviewed · How we verify
Generation of inducible pluripotent stem cells
Generation of inducible pluripotent stem cells is a Biologic drug developed by University of Alabama at Birmingham. It is currently in Phase 2 development.
At a glance
| Generic name | Generation of inducible pluripotent stem cells |
|---|---|
| Sponsor | University of Alabama at Birmingham |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Cell Collection to Study Eye Diseases
- Production of Stem Cells for the Generation of Pancreatic Cells (NA)
- Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
- Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC) (NA)
- Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
- Preparation of IPSC for Cell Gene Editing for the Treatment of AATD (NA)
- Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
- Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Generation of inducible pluripotent stem cells CI brief — competitive landscape report
- Generation of inducible pluripotent stem cells updates RSS · CI watch RSS
- University of Alabama at Birmingham portfolio CI
Frequently asked questions about Generation of inducible pluripotent stem cells
What is Generation of inducible pluripotent stem cells?
Generation of inducible pluripotent stem cells is a Biologic drug developed by University of Alabama at Birmingham.
Who makes Generation of inducible pluripotent stem cells?
Generation of inducible pluripotent stem cells is developed by University of Alabama at Birmingham (see full University of Alabama at Birmingham pipeline at /company/university-of-alabama-at-birmingham).
What development phase is Generation of inducible pluripotent stem cells in?
Generation of inducible pluripotent stem cells is in Phase 2.
Related
- Manufacturer: University of Alabama at Birmingham — full pipeline